Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance

被引:14
|
作者
Tandon, Rati [1 ]
Chandra, Sharat [2 ]
Baharia, Rajendra Kumar [1 ]
Das, Sanchita [1 ]
Misra, Pragya [1 ]
Kumar, Awanish [1 ]
Siddiqi, Mohammad Imran [2 ]
Sundar, Shyam [3 ]
Dube, Anuradha [1 ]
机构
[1] Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Struct & Mol Biol, Lucknow 226001, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India
关键词
IN-VITRO; DRUG-RESISTANCE; NITRIC-OXIDE; PROTEIN; PCNA; VIVO; PEPTIDES; IDENTIFICATION; PROMASTIGOTE; EXPRESSION;
D O I
10.1128/AAC.01847-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previously, through a proteomic analysis, proliferating cell nuclear antigen (PCNA) was found to be overexpressed in the sodium antimony gluconate (SAG)-resistant clinical isolate compared to that in the SAG-sensitive clinical isolate of Leishmania donovani. The present study was designed to explore the potential role of the PCNA protein in SAG resistance in L. donovani. For this purpose, the protein was cloned, overexpressed, purified, and modeled. Western blot (WB) and real-time PCR (RT-PCR) analyses confirmed that PCNA was overexpressed by >= 3-fold in the log phase, stationary phase, and peanut agglutinin isolated procyclic and metacyclic stages of the promastigote form and by similar to 5-fold in the amastigote form of the SAG-resistant isolate compared to that in the SAG-sensitive isolate. L. donovani PCNA (LdPCNA) was overexpressed as a green fluorescent protein (GFP) fusion protein in a SAG-sensitive clinical isolate of L. donovani, and modulation of the sensitivities of the transfectants to pentavalent antimonial (Sb-V) and trivalent antimonial (Sb-III) drugs was assessed in vitro against promastigotes and intracellular (J774A.1 cell line) amastigotes, respectively. Overexpression of LdPCNA in the SAG-sensitive isolate resulted in an increase in the 50% inhibitory concentrations (IC50) of Sb-V (from 41.2 +/- 0.6 mu g/ml to 66.5 +/- 3.9 mu g/ml) and Sb-III (from 24.0 +/- 0.3 mu g/ml to 43.4 +/- 1.8 mu g/ml). Moreover, PCNA-overexpressing promastigote transfectants exhibited less DNA fragmentation compared to that of wild-type SAG-sensitive parasites upon SbIII treatment. In addition, SAG-induced nitric oxide (NO) production was found to be significantly inhibited in the macrophages infected with the transfectants compared with that in wild-type SAG-sensitive parasites. Consequently, we infer that LdPCNA has a significant role in SAG resistance in L. donovani clinical isolates, which warrants detailed investigations regarding its mechanism.
引用
收藏
页码:2997 / 3007
页数:11
相关论文
共 50 条
  • [1] Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance
    Bhandari, Vasundhra
    Kumar, Dhiraj
    Verma, Sandeep
    Srividya, Gurumurthy
    Negi, Narendra Singh
    Singh, Ruchi
    Salotra, Poonam
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (04) : 646 - 651
  • [2] The distribution pattern of proliferating cell nuclear antigen in the nuclei of Leishmania donovani
    Kumar, Devanand
    Minocha, Neha
    Rajanala, Kalpana
    Saha, Swati
    MICROBIOLOGY-SGM, 2009, 155 : 3748 - 3757
  • [3] Antimony-Resistant Clinical Isolates of Leishmania donovani Are Susceptible to Paromomycin and Sitamaquine
    Kulshrestha, Arpita
    Singh, Ruchi
    Kumar, Dhiraj
    Negi, Narender Singh
    Salotra, Poonam
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2916 - 2921
  • [4] Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
    Purkait, Bidyut
    Kumar, Ashish
    Nandi, Nilay
    Sardar, Abul Hasan
    Das, Sushmita
    Kumar, Sudeep
    Pandey, Krishna
    Ravidas, Vidyananda
    Kumar, Manish
    De, Tripti
    Singh, Dharmendra
    Das, Pradeep
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) : 1031 - 1041
  • [5] Drug resistance mechanisms in clinical isolates of Leishmania donovani
    Singh, Neeloo
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2006, 123 (03) : 411 - 422
  • [6] Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani
    Kumar, Dhiraj
    Singh, Ruchi
    Bhandari, Vasundhra
    Kulshrestha, Arpita
    Negi, Narendra Singh
    Salotra, Poonam
    PARASITOLOGY RESEARCH, 2012, 111 (01) : 223 - 230
  • [7] Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani
    Potvin, Jade-Eva
    Leprohon, Philippe
    Queffeulou, Marine
    Sundar, Shyam
    Ouellette, Marc
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (10) : E526 - E532
  • [8] Molecular cloning and characterization of proliferating cell nuclear antigen; its potential involvement in germ cell development of stony corals
    Shikina, Shinya
    Chiu, Yi-Ling
    Ye, Man-ru
    Yao, Jack-I-Chen
    Chung, Yi-Jou
    Chen, Chieh-Jhen
    Chang, Ching-Fong
    FISHERIES SCIENCE, 2018, 84 (05) : 765 - 775
  • [9] The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA)
    Mahler, Michael
    Miyachi, Kiyomitsu
    Peebles, Carol
    Fritzler, Marvin J.
    AUTOIMMUNITY REVIEWS, 2012, 11 (10) : 771 - 775
  • [10] Downregulation of Mitogen-Activated Protein Kinase 1 of Leishmania donovani Field Isolates Is Associated with Antimony Resistance
    Ashutosh
    Garg, Mansi
    Sundar, Shyam
    Duncan, Robert
    Nakhasi, Hira L.
    Goyal, Neena
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) : 518 - 525